Katie Love, MD New Study of Type 1 Diabetes Enrolling Participants

April 4, 2023 by

Katie Love

Katie Love, MD

Katie Love, MD, an endocrinologist and principal investigator for the study HSR210198-Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes is currently enrolling participants. The overarching goals of this study is to better understand how and in what ways exercise or a medication called dulaglutide might help people with type 1 diabetes.

Read more about Dr. Love’s study and its real-life applications on the Exercise Physiology Core Laboratory website.  

To inquire about referring a patient or enrolling in the study, contact Dr. Love or the study coordinator Lee Hartline.


Filed Under: Research